Filip Przytuła

Filip Przytuła, MD

Dr Filip Przytuła is a graduate of the Medical Faculty of the Medical University of Gdańsk. Currently, he is in the process of specialising in neurology. Dr Przytuła is involved in many clinical trials for the treatment of Parkinson's disease, which keeps him up to date with the latest discoveries in neurology. As part of his professional practice, he manages patients burdened with advanced Parkinson's disease treated with deep brain stimulation (DBS). He has authored scientific publications on the successful treatment of Parkinson's disease and movement disorders after COVID-19. He constantly develops his skills and actively participates in neurological conferences to convey to patients the latest developments in the world of medicine and propose the most effective treatment methods.

Specialization:

• Neurologist

Patient`s age:

• adult

The doctor deals with:

• Neurological consultations
• Controlling brain stimulators in the treatment of Parkinson's disease, dystonia, and essential tremor

Education:

• 2011 – 2017: Medical University of Gdańsk, Faculty of Medicine
• Since 2019, he has been in the process of specialising in neurology

Professional experience:

• Neurology and Stroke Department of St. Wojciech Hospital in Gdańsk
• Extrapyramidal Diseases Clinic at St. Wojciech Hospital in Gdańsk
• Rehabilitation Department of the Specialist Hospital in Kościerzyna
• District Hospital in Tczew
• Van Ommerenpark, Wassenaar, the Netherlands - medical assistant

Language proficiency:

• Polish
• English

Trainings, courses and certificates:

• 01-04 May 2021 - 26th World Congress on Parkinson’s Disease and Related Disorders
• 15-18 September 2021 - 24th Congress of the Polish Neurological Society
• 26-27 November 2021 – "Neurodegenerations" Conference
• 01-04 May 2022 - 27th World Congress on Parkinson’s Disease and Related Disorders
• 14-17 September 2022 - 7th Scientific and Training Conference of the Polish Neurological Society
• 10-11 October 2019 - DBS Directional Programming Course Abbott, Prague, Czech Republic
• 29- 30 November 2019 - Unmet Needs in Advanced Parkinson's Disease Management, Vienna, Austria

Publications:

• Przytuła F, Dulski J, Sobstyl M, Sławek J. Battery for deep brain stimulation depletion in Parkinson's Disease and dystonia patients - a systematic review. Neurol Neurochir Pol. 2021;55(4):346-350. doi: 10.5603/PJNNS.a2021.0041. Epub 2021 May 31. PMID: 34056704
• Przytuła F, Błądek S, Sławek J. Two COVID-19-related video-accompanied cases of severe ata-ia-myoclonus syndrome. Neurol Neurochir Pol. 2021;55(3):310-313. doi: 10.5603/PJNNS.a2021.0036. Epub 2021 Jun 7. PMID: 34096013
• Przytuła F, Sławek J. Witaminy z grupy B w leczeniu powikłań neurologicznych infekcji COVID-19. Polski Przegląd Neurologiczny 17.4 (2021): 165-175
• Przytuła F, Sławek J. Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination - an update. Neurol Neurochir Pol. 2023;57(1):63-76. doi: 10.5603/PJNNS.a2023.0012. Epub 2023 Feb 17. PMID: 36799521
• Przytuła F, Kasprzak J, Dulski J, Koziorow-ski D, Kwaśniak-Butowska M, Sołtan W, Roszmann A, Śmiłowska K, Schinwelski M, Sławek J. Morbidity and severity of COVID-19 in patients with Parkinson's disease treated with amantadine - A multicentre, retrospective, observational study. Parkinsonism Relat Disord. 2023 Jan;106:105238. doi: 10.1016/j.parkreldis.2022.105238. Epub 2022 Dec 6. PMID: 36509028; PMCID: PMC9724557
• Przytuła F, Sławek J. Post-COVID-19 Myoclonus-Ataxia Syndrome-Is there Really a Need for Intravenous Immu-noglobulin Treatment in all Cases? Mov Disord Clin Pract. 2023 Mar 25;10(4):724-725. doi: 10.1002/mdc3.13695. PMID: 37070049; PMCID: PMC10105119

 

Location:

Medicover Centre Forum
Targ Sienny 7,
80-806 Gdańsk